These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 10051728

  • 1. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
    Wang JH, Devalia JL, Rusznak C, Bagnall A, Sapsford RJ, Davies RJ.
    Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
    [Abstract] [Full Text] [Related]

  • 2. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
    Wang JH, Devalia JL, Duddle JM, Hamilton SA, Davies RJ.
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis.
    Wang D, Duyck F, Smitz J, Clement P.
    Allergy; 1998 Apr; 53(4):375-82. PubMed ID: 9574879
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
    Nielsen LP, Bjerke T, Christensen MB, Skamling M, Peterson CG, Mygind N, Dahl R.
    Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
    [Abstract] [Full Text] [Related]

  • 8. Nitrogen dioxide increases eosinophil activation in the early-phase response to nasal allergen provocation.
    Wang JH, Duddle J, Devalia JL, Davies RJ.
    Int Arch Allergy Immunol; 1995 Aug; 107(1-3):103-5. PubMed ID: 7613114
    [Abstract] [Full Text] [Related]

  • 9. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
    Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.
    Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
    [Abstract] [Full Text] [Related]

  • 10. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P, Fokkens W.
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [Abstract] [Full Text] [Related]

  • 11. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G, Tosca MA, Passalacqua G, Canonica GW.
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
    [Abstract] [Full Text] [Related]

  • 12. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R.
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [Abstract] [Full Text] [Related]

  • 13. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
    Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay AB, Hamid Q, Löwhagen O, Durham SR.
    Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
    [Abstract] [Full Text] [Related]

  • 14. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
    Greiff L, Petersen H, Mattsson E, Andersson M, Erjefält JS, Linden M, Svensson C, Persson CG.
    Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
    [Abstract] [Full Text] [Related]

  • 15. Effect of slow-release theophylline on nasal antigen challenge in subjects with allergic rhinitis.
    Aubier M, Neukirch C, Maachi M, Boucara D, Engelstätter R, Steinijans V, Samoyeau R, Dehoux M.
    Eur Respir J; 1998 May; 11(5):1105-10. PubMed ID: 9648963
    [Abstract] [Full Text] [Related]

  • 16. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
    Jen A, Baroody F, de Tineo M, Haney L, Blair C, Naclerio R.
    J Allergy Clin Immunol; 2000 Apr; 105(4):732-8. PubMed ID: 10756223
    [Abstract] [Full Text] [Related]

  • 17. Intranasal fluticasone propionate reduces ICAM-1 on nasal epithelial cells both during early and late phase after allergen challenge.
    Ciprandi G, Ricca V, Passalacqua G, Fasolo A, Canonica GW.
    Clin Exp Allergy; 1998 Mar; 28(3):293-9. PubMed ID: 9543078
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
    Krug N, Gupta A, Badorrek P, Koenen R, Mueller M, Pivovarova A, Hilbert J, Wetzel K, Hohlfeld JM, Wood C.
    J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
    [Abstract] [Full Text] [Related]

  • 19. Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways.
    Erjefält JS, Greiff L, Andersson M, Matsson E, Petersen H, Linden M, Ansari T, Jeffery PK, Persson CG.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):304-12. PubMed ID: 10390416
    [Abstract] [Full Text] [Related]

  • 20. Does nitrogen dioxide affect inflammatory markers after nasal allergen challenge?
    Barck C, Lundahl J, Holmström M, Bylin G.
    Am J Rhinol; 2005 Jul; 19(6):560-6. PubMed ID: 16402641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.